During the past decade, Medical Technologies Ltd conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Technologies Ltd" #1 sponsor was "Pfizer" with 7 trials, followed by "Biocad" with 4 trials sponsored, "Amgen" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Technologies Ltd" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Atlant Clinical LLC" with 1 trials as a collaborator, "Center of Pharmaceutical Analytics LLC" with 1 trials as a collaborator, "Data Management 365" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Medical Technologies Ltd" are "Migraine" (4 trials), "Melanoma" (3 trials), "Cardiovascular Disease" (2 trials), "Cervical Cancer" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Medical Technologies Ltd" in a lesser frequency.

Most popular intervention types in "Medical Technologies Ltd" are "Drug" (21 trials), "Biological" (9 trials), "Other" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "BCD-100" (3 trials), "Bevacizumab" (2 trials), "Erenumab Dose 1" (2 trials) and "Erenumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Technologies Ltd" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Technologies Ltd". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Medical Technologies Ltd, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Technologies Ltd, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Medical Technologies Ltd has several departments that took part in Clinical trials: ""BioEq" LLC" - 3 trials